Company Filing History:
Years Active: 2021
Title: Suhaas Aluri: Innovator in Recombinant Polypeptides
Introduction
Suhaas Aluri is a notable inventor based in Los Angeles, California. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant polypeptides. His work focuses on innovative methods and therapeutics that have the potential to impact various medical applications.
Latest Patents
Suhaas Aluri holds one patent titled "CD20 scFv-ELPs methods and therapeutics." This patent discloses recombinant polypeptides that comprise an elastin-like peptide (ELP) and a single-chain variable fragment (scFv), or a biological equivalent of the scFv. The patent also details compositions containing scFv-ELP polypeptides and methods of use, showcasing his innovative approach to therapeutic development.
Career Highlights
Aluri is affiliated with the University of Southern California, where he continues to advance his research in biotechnology. His academic background and professional experience have equipped him with the skills necessary to contribute to the scientific community effectively.
Collaborations
Some of his notable coworkers include Alan L Epstein and John Andrew MacKay. Their collaboration has likely fostered an environment of innovation and creativity, further enhancing the impact of their collective research efforts.
Conclusion
Suhaas Aluri is a distinguished inventor whose work in recombinant polypeptides exemplifies the intersection of science and innovation. His contributions to biotechnology are paving the way for new therapeutic methods that could benefit many.